摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide | 113104-25-9

中文名称
——
中文别名
——
英文名称
2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide
英文别名
2-(7-nitrobenzo[c][1.2.5]oxadiazol-4-yl)thiopyridine-1-oxide;NSC 228155;NSC-228155;NSC228155;7-Nitro-4-(1-oxidopyridin-1-ium-2-yl)sulfanyl-2,1,3-benzoxadiazole
2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide化学式
CAS
113104-25-9
化学式
C11H6N4O4S
mdl
——
分子量
290.259
InChiKey
ICCFXXDUYSPKOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    627.3±65.0 °C(Predicted)
  • 密度:
    1.72±0.1 g/cm3(Predicted)
  • 溶解度:
    DMSO 中≥29 mg/mL;不溶于水;不溶于乙醇

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    136
  • 氢给体数:
    0
  • 氢受体数:
    7

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    |-20℃|

制备方法与用途

生物活性

NSC 228155 是一种 EGFR 激活剂,能与 EGFR 的胞外区域结合,诱导 EGFR 的磷酸化。此外,它还是一种有效的 KIX-KID 相互作用抑制剂,IC50 值为 0.36 μM,能够抑制 CREB 的激酶诱导结构域 (KID) 和 KIX (KID 相互作用结构域,来自 CBP) 的相互作用。

靶点 IC50 (μM)
EGFR
KIX-KID 0.36
体外研究

NSC 228155 (100 μM) 能通过 SOD1 的作用增强 EGFR 端酪氨酸的磷酸化。

在活的 HEK 293T 细胞中,NSC 228155 (Compound 1) 抑制 CREB-和 VP16-CREB 介导的基因转录,IC50 值分别为 2.09 μM 和 6.14 μM。然而,NSC 228155 并不选择性地抑制 CREB 介导的基因转录。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide二甲氨基硫代甲酰氯 作用下, 以 乙腈 为溶剂, 以29%的产率得到2-(7-nitrobenzo[c][1.2.5]oxadiazol-4-yl)thiopyridine
    参考文献:
    名称:
    Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription
    摘要:
    Cyclic-AMP response-element binding protein (CREB) is a stimulus-activated transcription factor. Its transcription activity requires its binding with CREB-binding protein (CBP) after CREB is phosphorylated at Ser133. The domains involved for CREB-CBP interaction are kinase-inducible domain (KID) from CREB and KID-interacting domain (KIX) from CBP. Recent studies suggest that CREB is an attractive target for novel cancer therapeutics. To identify novel chemotypes as inhibitors of KIX-KID interaction, we screened the NCI-diversity set of compounds using a split renilla luciferase assay and identified 2-[(7-nitrobenzo[ c][1,2,5]oxadiazol-4-yl)thio] pyridine 1-oxide (compound 1, NSC228155) as a potent inhibitor of KIX-KID interaction. However, compound 1 was not particularly selective against CREB-mediated gene transcription in living HEK 293T cells. Further structure-activityrelationship studies identified 4-aniline substituted nitrobenzofurazans with improved selectivity. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.07.053
  • 作为产物:
    描述:
    4-氯-7-硝基苯并-2-氧杂-1,3-二唑2-巯基吡啶-N-氧化物丙酮 为溶剂, 反应 0.17h, 以46%的产率得到2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide
    参考文献:
    名称:
    Bem, Marioara; Radutiu, Ana Cristina; Voicescu, Mariana, Revue Roumaine de Chimie, 2018, vol. 63, # 2, p. 149 - 155
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • VALDEZ, DAVID;REIER, JOANN C., J. LIQUID CHROMATOGR., 10,(1987) N 10, 2133-2135
    作者:VALDEZ, DAVID、REIER, JOANN C.
    DOI:——
    日期:——
  • TREATMENT AND PREVENTION OF DISEASE MEDIATED BY WWP2
    申请人:National University of Singapore
    公开号:EP3983544A1
    公开(公告)日:2022-04-20
  • [EN] TREATMENT AND PREVENTION OF DISEASE MEDIATED BY WWP2<br/>[FR] TRAITEMENT ET PRÉVENTION D'UNE MALADIE MÉDIÉE PAR WWP2
    申请人:NAT UNIV SINGAPORE
    公开号:WO2020249710A1
    公开(公告)日:2020-12-17
    Methods of treating and preventing fibrosis and pathological inflammation through inhibition of WWP2 are disclosed, as well as agents for use in such methods.
  • Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription
    作者:Fuchun Xie、Bingbing X. Li、Candice Broussard、Xiangshu Xiao
    DOI:10.1016/j.bmcl.2013.07.053
    日期:2013.10
    Cyclic-AMP response-element binding protein (CREB) is a stimulus-activated transcription factor. Its transcription activity requires its binding with CREB-binding protein (CBP) after CREB is phosphorylated at Ser133. The domains involved for CREB-CBP interaction are kinase-inducible domain (KID) from CREB and KID-interacting domain (KIX) from CBP. Recent studies suggest that CREB is an attractive target for novel cancer therapeutics. To identify novel chemotypes as inhibitors of KIX-KID interaction, we screened the NCI-diversity set of compounds using a split renilla luciferase assay and identified 2-[(7-nitrobenzo[ c][1,2,5]oxadiazol-4-yl)thio] pyridine 1-oxide (compound 1, NSC228155) as a potent inhibitor of KIX-KID interaction. However, compound 1 was not particularly selective against CREB-mediated gene transcription in living HEK 293T cells. Further structure-activityrelationship studies identified 4-aniline substituted nitrobenzofurazans with improved selectivity. (C) 2013 Elsevier Ltd. All rights reserved.
  • Bem, Marioara; Radutiu, Ana Cristina; Voicescu, Mariana, Revue Roumaine de Chimie, 2018, vol. 63, # 2, p. 149 - 155
    作者:Bem, Marioara、Radutiu, Ana Cristina、Voicescu, Mariana、Caproiu, Miron T.、Draghici, Constantin、Maganu, Maria、Enache, Cristian、Constantinescu, Titus、Balaban, Alexandru T.
    DOI:——
    日期:——
查看更多